Through purpose-driven science, empowering medicines, and transformative advocacy we seek to improve the lives of millions.

Uterine Fibroids

An estimated 5 million people in the U.S. suffer from symptoms of uterine fibroids.

Learn more »

Prostate Cancer

Approximately 3 million people alive today in the U.S. have been diagnosed with prostate cancer.

Learn more »

MYOVANT STORIES

Overcoming Stigma with Care and Community

Thomasine’s journey through uterine fibroids started with pain but led to empowerment.

Read Thomasine’s Story

PURPOSE-DRIVEN SCIENCE

Myovant is developing innovative medicines that hold promise to improve people’s lives.

View our pipeline

TRANSFORMATIVE ADVOCACY

We’re partnering with cross-sector coalitions to fight stigma, raise awareness, and empower people with information.

Learn More

On Twitter

Tweets by Myovant

News

9 Sep 2021

Myovant Sciences and Pfizer Announce FDA Acceptance of Supplemental New Drug Application for MYFEMBREE® for the Management of Moderate to Severe Pain Associated With Endometriosis

1 Sep 2021

Myovant Sciences to Participate in the 2021 Baird Global Healthcare Conference

12 Aug 2021

Myovant Sciences Appoints Uneek Mehra as Chief Financial and Business Officer

28 Jul 2021

Myovant Sciences Announces Financial Results for First Quarter of Fiscal Year 2021 and Corporate Updates

View more news

You are leaving www.myovant.com, a website provided by Myovant Sciences GmbH.
This link will take you to a different site.

Confirm Close

Uterine Fibroids

Prostate Cancer

MYOVANT STORIES

Overcoming Stigma with Care and Community

PURPOSE-DRIVEN SCIENCE

TRANSFORMATIVE ADVOCACY

On Twitter

News

9 Sep 2021

1 Sep 2021

12 Aug 2021

28 Jul 2021

Events

15 Sep 2021

28 Jul 2021

17 Jun 2021

8 Jun 2021